Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia

Neuroscience Letters

Volumn 486, Issue 1, 2010, Pages 19-23

  Fujishiro, Hiroshige ^a,b   Iseki, Eizo ^a,b   Higashi, Shinji ^a   Kasanuki, Koji ^a,b   Murayama, Norio ^a   Togo, Takashi ^c   Katsuse, Omi ^c   Uchikado, Hirotake ^c   Aoki, Naoya ^c   Kosaka, Kenji ^c   Arai, Heii ^b   Sato, Kiyoshi ^a  

^a JUNTENDO TOKYO KOTO GERIATRIC MEDICAL CENTER   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

A ; DLB; Parkinsonism; PD; Synuclein; Tau

Indexed keywords

AMYLOID BETA PROTEIN;

ARTICLE; DIFFUSE LEWY BODY DISEASE; HUMAN; IMMUNOREACTIVITY; MESENCEPHALON; NEOCORTEX; NEUROFIBRILLARY TANGLE; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SCORING SYSTEM;

AGED; ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOLOGICAL MARKERS; BRAIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LEWY BODIES; LEWY BODY DISEASE; MALE; NEUROFIBRILLARY TANGLES; PARKINSON DISEASE; TAU PROTEINS;

EID: 77957924992     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.09.036     Document Type: Article

References (20)

1. Alafuzoff I., Arzberger T., Al-Sarraj S., Bodi I., Bogdanovic N., Braak H., Bugiani O., Del-Tredici K., Ferrer I., Gelpi E., Giaccone G., Graeber M.B., Ince P., Kamphorst W., King A., Korkolopoulou P., Kovacs G.G., Larionov S., Meyronet D., Monoranu C., Parchi P., Patsouris E., Roggendorf W., Seilhean D., Tagliavini F., Stadelmann C., Streichenberger N., Thal D.R., Wharton S.B., Kretzschmar H. Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium. Brain Pathol. 2008, 18:484-496.
2. Alafuzoff I., Thal D.R., Arzberger T., Bogdanovic N., Al-Sarraj S., Bodi I., Boluda S., Bugiani O., Duyckaerts C., Gelpi E., Gentleman S., Giaccone G., Graeber M., Hortobagyi T., Hoftberger R., Ince P., Ironside J.W., Kavantzas N., King A., Korkolopoulou P., Kovacs G.G., Meyronet D., Monoranu C., Nilsson T., Parchi P., Patsouris E., Pikkarainen M., Revesz T., Rozemuller A., Seilhean D., Schulz-Schaeffer W., Streichenberger N., Wharton S.B., Kretzschmar H. Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol. 2009, 117:309-320.
3. Ballard C., Ziabreva I., Perry R., Larsen J.P., O'Brien J., McKeith I., Perry E., Aarsland D. Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology 2006, 67:1931-1934.
4. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol. Aging 18 (1997) S1-S2.
5. Dickson D.W., Fujishiro H., Orr C., DelleDonne A., Josephs K.A., Frigerio R., Burnett M., Parisi J.E., Klos K.J., Ahlskog J.E. Neuropathology of non-motor features of Parkinson disease. Parkinsonism Relat. Disord. 2009, Suppl 3:S1-5.
6. Edison P., Rowe C.C., Rinne J.O., Ng S., Ahmed I., Kemppainen N., Villemagne V.L., O'Keefe G., Någren K., Chaudhury K.R., Masters C.L., Brooks D.J. Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J. Neurol. Neurosurg. Psychiatry 2008, 79:1331-1338.
7. Fujishiro H., Ferman T.J., Boeve B.F., Smith G.E., Graff-Radford N.R., Uitti R.J., Wszolek Z.K., Knopman D.S., Petersen R.C., Parisi J.E., Dickson D.W. Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases. J. Neuropathol. Exp. Neurol. 2008, 67:649-656.
8. Gomperts S.N., Rentz D.M., Moran E., Becker J.A., Locascio J.J., Klunk W.E., Mathis C.A., Elmaleh D.R., Shoup T., Fischman A.J., Hyman B.T., Growdon J.H., Johnson K.A. Imaging amyloid deposition in Lewy body diseases. Neurology 2008, 71:903-910.
9. Greffard S., Verny M., Bonnet A.M., Beinis J.Y., Gallinari C., Meaume S., Piette F., Hauw J.J., Duyckaerts C. Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra. Arch. Neurol. 2006, 63:584-588.
10. Hurtig H.I., Trojanowski J.Q., Galvin J., Ewbank D., Schmidt M.L., Lee V.M., Clark C.M., Glosser G., Stern M.B., Gollomp S.M., Arnold S.E. Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology 2000, 54:1916-1921.
11. Jellinger K., Attems J. Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?. Acta Neuropathol. 2006, 112:253-260.
12. Lashley T., Holton J.L., Gray E., Kirkham K., O'Sullivan S.S., Hilbig A., Wood N.W., Lees A.J., Revesz T. Cortical α-synuclein load is associated with amyloid-beta plaque burden in a subset of Parkinson's disease patients. Acta Neuropathol. 2008, 115:417-425.
13. Masliah E., Rockenstein E., Veinbergs I., Sagara Y., Mallory M., Hashimoto M., Mucke L. Beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:12245-12250.
14. Merdes A.R., Hansen L.A., Jeste D.V., Galasko D., Hofstetter C.R., Ho G.J., Thal L.J., Corey-Bloom J. Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology 2003, 60:1586-1590.
15. Maetzler W., Reimold M., Liepelt I., Solbach C., Leyhe T., Schweitzer K., Eschweiler G.W., Mittelbronn M., Gaenslen A., Uebele M., Reischl G., Gasser T., Machulla H.-J., Bares R., Berg D. [11C]PIB binding in Parkinson's disease dementia. Neuroimage 2008, 39:1027-1033.
16. McKeith I.G., Dickson D.W., Lowe J., Emre M., O'Brien J.T., Feldman H., Cummings J., Duda J.E., Lippa C., Perry E.K., Aarsland D., Arai H., Ballard C.G., Boeve B., Burn D.J., Costa D., Del Ser T., Dubois B., Galasko D., Gauthier S., Goetz C.G., Gomez-Tortosa E., Halliday G., Hansen L.A., Hardy J., Iwatsubo T., Kalaria R.N., Kaufer D., Kenny R.A., Korczyn A., Kosaka K., Lee V.M., Lees A., Litvan I., Londos E., Lopez O.L., Minoshima S., Mizuno Y., Molina J.A., Mukaetova-Ladinska E.B., Pasquier F., Perry R.H., Schulz J.B., Trojanowski J.Q., Yamada M. Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005, 65:1863-1872.
17. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991, 41:479-486.
18. Marui W., Iseki E., Kato M., Akatsu H., Kosaka K. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease. Acta Neuropathol. 2004, 108:121-128.
19. Pletnikova O., West N., Lee M.K., Rudow G.L., Skolasky R.L., Dawson T.M., Marsh L., Troncoso J.C. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases. Neurobiol. Aging 2005, 26:1183-1192.
20. Thal D.R., Rub U., Orantes M., Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 2002, 58:1791-1800.